$0.791
+0.057 (+7.22%)Zum Schluss
TELA-News
TELA-Events
Investors Pull Back Amid Geopolitical and Inflation Concerns
Stock futures are slightly lower as investors close out August with renewed geopolitical and inflation concerns. The pullback follows renewed fighting between the U.S. and Iran, which has pushed oil sharply higher and raised concerns about another inflationary shock.Brent crude has climbed above $90 a barrel, while WTI is around $86, after U.S. forces struck Iranian rocket launchers near the Strait of Hormuz and Iran retaliated against U.S. forces in the region.Markets are now pricing roughly a 60% probability of a September rate hike, up from about 41% a week ago. Fed Chair Kevin Warsh's hawkish Jackson Hole comments, combined with renewed energy-price pressures, have pushed investors to reconsider expectations for monetary easing.The market is nevertheless finishing a strong August. The S&P 500 is up roughly 3% for the month, the Nasdaq about 4% and the Dow about 2%, according to premarket data. The gains have been driven largely by technology and AI stocks. Attention now turns to a data-heavy first week of September. The ISM manufacturing report is due Tuesday, followed by the August employment report Friday. The jobs report will be particularly important for the Fed after July's disappointing payroll reading, with economists expecting employment to rebound in August.In pre-market trading, S&P 500 futures fell 0.36%, Nasdaq futures fell 0.32% and Dow futures fell 0.37%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -SLBup 1% after signing an agreement to acquire Kelvion for $3.4B in cashUP AFTER EARNINGS -SAICup 11%BioLineRxup 9%GameStopup 3%UP AFTER RENEWED STRIKES IN THE MIDDLE EAST -Halliburtonup 2%Chevronup 2%Valeroup 2%Occidentalup 2%Exxon Mobilup 2%LOWER -PG&E, Edison Internationaland Sempra Energydown 16%, 15% and 3%, respectively, afterCalifornia lawmakers are barring Governor Gavin Newsom from moving forward with his plan to prevent insurers in the state from recouping their losses from investor-owned utilities that cause a catastrophic wildfireTela Bio (TELA) down 5% after announcing that Roberto Cuca, COO and CFO, will step down from the role effective immediatelyPinterestdown 3% after disclosing that Julia Brau Donnelly, CFO, submitted her resignation to Pinterest to pursue another opportunityAon plcdown 1% after entering a definitive agreement to acquire USI from KKRand other shareholders for a total purchase price of $17B
Tela Bio COO and CFO Roberto Cuca Steps Down Immediately
Tela Bio announced that Roberto Cuca, COO and CFO, will step down from the role effective immediately. CEO Heather Getz commented, "At the same time, we are implementing a broader initiative to strengthen our cost structure and position TELA Bio for long-term success. Over the last month, we have conducted a comprehensive review of our business and corporate infrastructure to identify opportunities to operate more efficiently. As a result, we have taken actions to reduce our annual operating expenses by approximately $17.0 million across the organization. These savings will be driven by a targeted headcount reduction of approximately 20% and the streamlining of external resources, while preserving our ability to invest in our core growth priorities and product innovation. We are focused on disciplined execution, strengthening the business, and creating a more efficient organization positioned to deliver sustainable long-term growth and expect this initiative to extend our cash runway into 2028." Tela Bio anticipates incurring a one-time restructuring charge of approximately $1.5M in the third quarter of 2026, primarily related to severance and other employee-related costs. The company intends to provide additional details and commentary regarding the cost reduction initiatives during its third quarter 2026 earnings call, planned for early November.
Company Withdraws Full-Year Guidance
The company said, "The Company has withdrawn full-year guidance and will provide an update in the future."
TELA Bio Q2 Revenue at $19.29M, Below Consensus
Reports Q2 revenue $19.29M, consensus $20.01M. "Unfortunately, the financial performance of the business does not reflect the superiority of the portfolio. Our second quarter revenue was negatively impacted by a decline in OviTex PRS volumes and continued price and mix headwinds in hernia procedures. In response, we have returned to a sales structure designed to reinforce cross-selling among our field teams, and with a clear focus on returning to growth in the second half the year," said Heather Getz, newly appointed Chief Executive Officer of TELA Bio.
Tela Bio Appoints Heather Getz as CEO
Tela Bio (TELA) announced that the board of directors has appointed Heather Getz as CEO and director, effective immediately. Getz joins Tela Bio having most recently served as executive VP and chief financial and operations officer at Butterfly Network (BFLY).
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.




